Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Psychiatrische Praxis|September 2, 2020
[Delusional Misidentification Syndrom and Violent Behavior - Risk Assessment and Management]Michael Rentrop, Stephan Sassenberg, Ljudmyla Massold, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 4, 2017
How well do patients with a first episode of schizophrenia respond to antipsychotics: A systematic review and meta-analysisYikang Zhu, Chunbo Li, Maximilian Huhn, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 18, 2021
The role of psycho-oncologic screenings in the detection and evaluation of depression in head and neck cancer aftercare patientsStefan Hadas, Maximilian Huhn, Michael Rentrop, et al.
The American Journal of Psychiatry|June 11, 2016
Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-AnalysisBartosz Helfer, Myrto T Samara, Maximilian Huhn, et al.
Schizophrenia Bulletin|August 10, 2021
Examining Side Effect Variability of Antipsychotic Treatment in Schizophrenia Spectrum Disorders: A Meta-analysis of VarianceMaria S Neumeier, Stephanie Homan, Stefan Vetter, et al.
Oncotarget|July 2, 2014
The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphismAnja Pickhard, Michael Siegl, Alexander Baumann, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 17, 2020
Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trialMaximilian Huhn, Claudia Leucht, Philipp Rothe, et al.
The Lancet. Psychiatry|July 26, 2018
Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trialsJohannes Schneider-Thoma, Orestis Efthimiou, Maximilian Huhn, et al.
Pageof 4